You are here: Industry Insights > COVID-19 Vaccine

News List

Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine americanpharmaceuticalreview
April 12, 2021
Moderna, Inc. highlighted the publication of antibody persistence data out to 6 months following the second dose of the Moderna COVID-19 Vaccine in The New England Journal of Medicine.
India to assess side effects of COVID-19 vaccine expresspharma
April 12, 2021
India is currently administering AstraZeneca's COVID-19 vaccine and a shot developed at home by Bharat Biotech.
SII repays South Africa for COVID-19 vaccines that were not delivered expresspharma
April 12, 2021
The Serum Institute of India has fully refunded South Africa for the 500,000 doses of the COVID-19 vaccine, which were not delivered to the country after it decided not to use the vaccine because it was not effective against a new variant of the virus.
Iran in discussions with India for second shipment of COVID-19 vaccines expresspharma
April 12, 2021
India has scaled down the export of coronavirus vaccines following a surge in the demand for those within the country in view of a rising number of COVID-19 cases.
Maha Health Minster asks Centre to formulate COVID-19 vaccine allotment criteria expresspharma
April 12, 2021
He alleged that many states which are smaller than Maharashtra in terms of population and the number of patients, have received more doses.
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia? in Chile prnasia
April 09, 2021
CanSino Biologics Inc. announced that the Instituto de Salud Pública de Chile ("ISP") granted emergency use authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia?).
Philippines halts use of AstraZeneca vaccine for people below 60 years pharmaceutical-technology
April 09, 2021
The Philippines Department of Health (DOH) has adopted the Food and Drug Administration’s (FDA) recommendation to temporarily put the use of the AstraZeneca Covid-19 vaccine on hold for individuals aged below 60 years.
COVAX has delivered vaccines to over 100 countries, despite supply hits: GAVI/WHO expresspharma
April 09, 2021
The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.
Benefits of AZ vaccine outweigh risks, says MHRA pharmatimes
April 08, 2021
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that there is a possible link between AstraZeneca's COVID-19 vaccine and “extremely rare, unlikely to occur blood clots”.
Scottish COVID-19 vaccine shows ‘strong immune response’ in early UK trials expresspharma
April 08, 2021
The vaccine, called VLA2001, also induced T-cell responses, which help the body fend off a virus and determine long-lasting immunity.